• FDA Panel Narrowly Backs a First-of-a-Kind COVID-19 Antiviral Pill Made By Merck

    1 month ago - By Time

    WASHINGTON - A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck , setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus.
    A Food and Drug Administration panel voted 13-10 that the drug's benefits outweigh its risks, including potential birth defects if used during pregnancy. The recommendation came after hours of debate about the drug's modest benefits and potential safety issues. Experts backing the treatment stressed that it should not be used by anyone who is pregnant...
    Read more ...

     

  • FDA panel narrowly recommends authorization of Merck Covid pill after day of tense discussion

    1 month ago - By STAT

    A panel of experts convened by the Food and Drug Administration voted by a slim margin on Tuesday to recommend the agency authorize the Covid treatment developed by Merck and partner Ridgeback Biotherapeutics, after a vigorous debate about the risks and benefits of the first oral drug to combat the SARS-CoV-2 virus.
    The FDA is not obligated to follow the advice of the panels it convenes, but it usually does.
    Read more ...